Impact of Emotional Skills of Young Women and Their Partner on Adjustment to Cancer

NCT02861742 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 391

Last updated 2026-03-18

No results posted yet for this study

Summary

The KALICOU 3 study will evaluate the effect of emotional skills of patients and their partners on their individual disease subjective experience during care pathways, from chemotherapy to surveillance.

Conditions

Interventions

OTHER

Delivery of questionnaires

After patient and partner information, clinical research associate or clinical research nurse will give to the couple 2 booklets containing 5 questionnaires, respectively T1, T2, T3, T4 and T5.

BEHAVIORAL

Questionnaire T1 to fill

T1 is to fill before chemotherapy.

BEHAVIORAL

Questionnaire T2 to fill

T2 is to fill after the 6th cycle of chemotherapy.

BEHAVIORAL

Questionnaire T3 to fill

T3 is to fill at the end of radiotherapy.

BEHAVIORAL

Questionnaire T4 to fill

T4 is to fill 4 month after beginning of hormonotherapy or surveillance if no hormonotherapy.

BEHAVIORAL

Questionnaire T5 to fill

T5 is to fill 1 year after the beginning of hormonotherapy or surveillance if no hormonotherapy.

Sponsors & Collaborators

  • Université Lille 3

    collaborator UNKNOWN
  • Aix Marseille Université

    collaborator OTHER
  • University of Paris 5 - Rene Descartes

    collaborator OTHER
  • SIRIC ONCOLille

    collaborator UNKNOWN
  • Canceropôle Nord Ouest

    collaborator OTHER
  • National Cancer Institute, France

    collaborator OTHER_GOV
  • Centre Oscar Lambret

    lead OTHER

Principal Investigators

  • Laurence VANLEMMENS, MD · Oscar Lambret

  • Véronique CHRISTOPHE, PhD · Université Lille 3

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-25
Primary Completion
2021-06-30
Completion
2022-01-31

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02861742 on ClinicalTrials.gov